Skip to main content

Pharmacy management company CarepathRx to acquire Chartwell from UPMC for $400 million

UPMC will become a strategic investor in CarepathRx as part of the acquisition.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.